Viewing Study NCT05398861


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-01-06 @ 3:19 PM
Study NCT ID: NCT05398861
Status: UNKNOWN
Last Update Posted: 2022-06-01
First Post: 2022-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module